StonvexLoading…
StonvexStonvexStonvexCore line items from AMTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $54.62M | $197.63M | $154.32M | $95.13M |
Operating Income | $-6.33M | $-37.22M | $-34.74M | $-26.23M |
Net Income | $-21.71M | $-77.00M | $-71.67M | $-23.39M |
EPS (Diluted) | $-0.33 | $-1.28 | $-1.24 | $-0.87 |
Total Assets | $270.33M | $259.84M | $241.12M | $240.02M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $4.80M | $4.89M | $5.58M | $1.65M |
Free Cash Flow OCF − CapEx | $-17.11M | $-22.74M | $-11.95M | $-10.93M |
Shares Outstanding | 66.80M | 66.19M | 65.00M | 61.99M |